Journal of Cancer Research and Therapeutics
Medknow Publications on behalf of the Association of Radiation Oncologists of India (AROI)
Vol. 5, No. 2, 2009, pp. 140-142
Bioline Code: cr09036
Full paper language: English
Document type: Case Report
Document available free of charge
Journal of Cancer Research and Therapeutics, Vol. 5, No. 2, 2009, pp. 140-142
© Copyright 2009 Journal of Cancer Research and Therapeutics.
Diffuse large B-cell lymphoma of the uterine cervix: A rare case managed novelly|
Baijal, Gunjan; Vadiraja, BM; Fernandes, DonaldJ & Vidyasagar, MS
Non-Hodgkin′s lymphoma (NHL) of the uterine cervix is exceedingly rare. The management of the disease is not standardized. A 44-year-old lady presented with a history of bleeding pervaginum and a foul-smelling discharge of 2 months′ duration. A 7 x 7 growth was seen in the cervix. A biopsy revealed it to be a CD20-positive diffuse large B-cell (DLBCL)-type NHL. She was diagnosed as stage IE after staging work-up, and managed with three courses of rituximab, cyclophosphamide, vincristine, adriamycin, and prednisolone followed by external beam radiotherapy (46 Gy in 23 fractions) by 3D conformal technique. She attained a complete response, and has been in remission for 1 year 3 months.
Non-Hodgkin′s lymphoma, rituximab, uterine cervix
Alternative site location: http://www.cancerjournal.net/